The rising frequency of disorders such as cancer, lymphoma, and others that necessitate bone marrow transplants, as well as increased research and development efforts for bone marrow transplants, are likely to fuel market expansion over the forecast period. Because of the challenges related with the COVID-19 epidemic, the bone marrow transplant market suffered. A bone marrow transplant, for example, might result in fatal pulmonary problems. The paucity of bone marrow donors and the high cost of bone marrow transplant are two main factors impeding the growth of the global bone marrow transplant market. In the United States, for example, autologous bone marrow transplants cost roughly $360,000 while allogeneic bone marrow transplants cost over $800,000.
According to Coherent Market Insights, Global Bone Marrow Transplant Market is estimated to be valued at US$ 10,356.1 million in 2022 and is expected to exhibit a CAGR of 4.0% during the forecast period (2022-2030).
Key Competitors in the Bone Marrow Transplant Industry:
1. Lonza, Merck KgaA
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany.
2. AllCells
Founded in 1998, AllCells, a Discovery Life Sciences company, is a market-leading provider of highly characterized primary cell and tissue products, supporting global biomedical organizations seeking to develop and manufacture novel drugs and cell therapies. On Feb. 22, 2023 All cells announced the expansion of its apheresis network with the addition of two new in Houston, Texas, and Huntsville, Alabama. The company is headquartered in California.
3. STEMCELL Technologies Inc.
Developer of life science research products. The company's products include cell culture media and supplements, cell isolation products, primary and cultured cells, cytokines, matrices and substrates, enabling scientists to perform stem cell, immunology, cancer, regenerative medicine and cellular therapy research globally. Founded in 1993, headquartered in Canada.
4. Charles River Laboratories
On 10.19.22 Charles River Laboratories International Inc. has launched a new digital donor experience to enhance access to its donor centers in four distinct US geographic markets. Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company is headquartered in Wilmington, U.S.
5. Beike Biotechnology Co., Ltd.
Developer and provider of stem cell therapies. The company produces a full line of innovative stem cell products derived from umbilical cord, cord blood, and bone marrow stem cells, enabling hospitals to offer immune cells and stem cell therapies for unmet medical needs. Founded in 2005, headquartered in China.
6. FUJIFILM Cellular Dynamics, Inc.
Founded in 2004, headquartered in Madison. Manfucaturer and developer of human cells intended to be used in drug discovery, toxicity testing, stem cell banking, and cell therapy development.
7. CORESTEM, Inc.
Corestemchemon Inc formerly Corestem Inc is a South Korea based company Biopharmaceutical Company. It is primarily engaged in the business activity of developing and producing stem cell therapy for the treatment of incurable diseases. Founded in 2003.
8. Gamida Cell
On Nov. 21, 2022 Gamida Cell Ltd., the leader in the development of NAM-enabled cell therapies for patients with hematological and solid cancers and other serious diseases, today provided an update on recent interactions with the U.S. Food and Drug Administration (FDA) relating to the company’s Biologics License Application (BLA) for omidubicel, the company’s advanced cell therapy candidate for allogeneic hematopoietic stem cell transplant. The company was founded in 1998, headquartered in Jerusalem, Israel.
9. Mesoblast Ltd
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Founded in 2004, headquartered in Australia.
*Definition- In the core of lengthy bones, there is a soft vascular tissue called bone marrow. Hematopoietic and mesenchymal stem cells make up both kinds of stem cells.
